Diseases and therapeutic areas
Radiomics.bio has become one of the leading experts in advanced image analysis for clinical oncology. We use our in-depth AI expertise combined with clinical and therapeutic know-how to facilitate decision-making in clinical practice and drug development. During the COVID-19 pandemic, Radiomics.bio has also been able to demonstrate that our technology can be successfully applied to a multitude of respiratory diseases. Many other clinical fields can benefit from a radiomics approach and our team is constantly working, in collaboration with researchers, clinicians and treatment providers, to address relevant unmet clinical needs.
Together with its partners, Radiomics.bio is continuously working towards better personalized medicine for the patients of today and tomorrow, leading the way to tailored and patient-centered solutions.
Radiomics.bio features extracted from standard-of-care medical images are extremely useful in cancer diagnosis, prognosis and treatment selection.
Radiomics.bio solutions can be
applied to lung CT images to
assess pulmonary function.